These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10908166)

  • 21. Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy.
    Verburg FA; Smit JW; Grelle I; Visser TJ; Peeters RP; Reiners C
    Clin Endocrinol (Oxf); 2012 Apr; 76(4):577-81. PubMed ID: 22017394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Increase in TSH levels in thyroid carcinoma patients after withdrawal of suppressive levothyroxine medication].
    Hackländer S; Voth E; Schicha H
    Nuklearmedizin; 1996 Oct; 35(5):170-4. PubMed ID: 9005413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of a sensitive thyrotropin assay for monitoring treatment with levothyroxine.
    Watts NB
    Arch Intern Med; 1989 Feb; 149(2):309-12. PubMed ID: 2644903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Double-Blind Placebo-Controlled Trial of Liquid Thyroxine Ingested at Breakfast: Results of the TICO Study.
    Cappelli C; Pirola I; Daffini L; Formenti A; Iacobello C; Cristiano A; Gandossi E; Agabiti Rosei E; Castellano M
    Thyroid; 2016 Feb; 26(2):197-202. PubMed ID: 26586610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study between the effects of replacement therapy with liquid and tablet formulations of levothyroxine on mood states, self-perceived psychological well-being and thyroid hormone profile in recently thyroidectomized patients.
    Lombardi CP; Bocale R; Barini A; Barini A; D'Amore A; Boscherini M; Bellantone R
    Endocrine; 2017 Jan; 55(1):51-59. PubMed ID: 27388589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid hormone resistance and pituitary enlargement after thyroid ablation in a woman on levothyroxine treatment.
    Marazuela M; Nattero L; Moure D; García-Polo I; Figueroa-Vega N; Guijarro C
    Thyroid; 2008 Oct; 18(10):1119-23. PubMed ID: 18816177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of overt and subclinical hypothyroidism. Factors influencing L-thyroxine dosage.
    Rezzónico JN; Pusiol E; Saravi FD; Rezzónico M; Bossa N
    Medicina (B Aires); 1999; 59(6):698-704. PubMed ID: 10752211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversible pituitary enlargement in the syndrome of resistance to thyroid hormone.
    Gurnell M; Rajanayagam O; Barbar I; Jones MK; Chatterjee VK
    Thyroid; 1998 Aug; 8(8):679-82. PubMed ID: 9737363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of levothyroxine supplementation in extremely low birth weight infants who have transient hypothyroidism without thyroid-stimulating hormone elevation.
    Nomura S; Ikegami H; Wada H; Tamai H; Funato M; Shintaku H
    Osaka City Med J; 2014 Jun; 60(1):29-37. PubMed ID: 25272565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism.
    Shimon I; Cohen O; Lubetsky A; Olchovsky D
    Thyroid; 2002 Sep; 12(9):823-7. PubMed ID: 12481949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excessive thyroid hormone replacement therapy.
    Nuovo J; Ellsworth A; Christensen DB; Reynolds R
    J Am Board Fam Pract; 1995; 8(6):435-9. PubMed ID: 8585400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.
    Appetecchia M
    Horm Res; 2005; 64(6):293-8. PubMed ID: 16269872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new strategy to estimate levothyroxine requirement after total thyroidectomy for benign thyroid disease.
    Di Donna V; Santoro MG; de Waure C; Ricciato MP; Paragliola RM; Pontecorvi A; Corsello SM
    Thyroid; 2014 Dec; 24(12):1759-64. PubMed ID: 25268754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid storm with encephalopathic symptoms due to Graves' disease and inappropriate secretion of thyrotropin.
    Modignani RL; Venegoni M; Beretta F; Fassina S
    Ann Ital Med Int; 1992; 7(4):250-4. PubMed ID: 1298337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypothyroidism due to nephrotic syndrome: a notable clinical entity.
    Fukata S; Ito M; Nishikawa M; Kasahara T; Nishihara E; Akamiuzu T; Miyauchi A
    Endocr J; 2022 Mar; 69(3):307-311. PubMed ID: 34615836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thyroxine vs iodine and thyroxine. Comparison of the TSH suppression test].
    Kahaly G; Mihaljevic V; Beyer J; Krause U
    Schweiz Med Wochenschr; 1989 Jan; 119(2):59-64. PubMed ID: 2492674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid hormone indices during illness in six hypothyroid subjects rendered euthyroid with levothyroxine therapy.
    Wadwekar D; Kabadi UM
    Exp Clin Endocrinol Diabetes; 2004 Jul; 112(7):373-7. PubMed ID: 15239022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Rifampin on Thyroid Function Test in Patients on Levothyroxine Medication.
    Kim HI; Kim TH; Kim H; Kim YN; Jang HW; Chung JH; Moon SM; Jhun BW; Lee H; Koh WJ; Kim SW
    PLoS One; 2017; 12(1):e0169775. PubMed ID: 28081173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Graves' disease and coexisting struma ovarii: struma expression of thyrotropin receptors and the presence of thyrotropin receptor stimulating antibodies.
    Teale E; Gouldesbrough DR; Peacey SR
    Thyroid; 2006 Aug; 16(8):791-3. PubMed ID: 16910883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.